Browse Title Index

Issue Title
Vol 11, No 4 (2015): July/August 12-Month safety and effectiveness of once-daily hydrocodone Abstract
Warren Wen, PhD, Louise Taber, MD, Shau Yu Lynch, PhD, Ellie He, PhD, Steven Ripa, MD
Vol 10, No 4 (2014): July/August 2014 INTERNATIONAL CONFERENCE ON OPIOIDS Posters presented June 8-10, 2014 Abstract
JOM Editors
Vol 12, No 6 (2016): November/December 2017 International Conference on Opioids Announcement Abstract
2017 ICOO Conference Committee
Vol 13, No 1 (2017): January/February 2017 International Conference on Opioids Brochure and Schedule Details
Conference Committee
Vol 12, No 6 (2016): November/December A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation Abstract
Lynn Webster, MD, Raj Tummala, MD, MBA, MS, Ulysses Diva, PhD, Jaakko Lappalainen, MD, PhD
Vol 10, No 3 (2014): May/June A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center Abstract
Yatan Pal Singh Balhara, MD, DNB, MNAMS
Vol 13, No 2 (2017): March/April A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications Abstract
Corey J. Hayes, PharmD, MPH, Jacob T. Painter, PharmD, MBA, PhD
Vol 12, No 6 (2016): November/December A more balanced approach to opioid use and management is also needed in end-of-life care Abstract
Sydney Morss Dy, MD, MSc, Cynda Hylton Rushton, PhD, RN, FAAN
Vol 10, No 6 (2014): November/December A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain Abstract
Samir Arora, MD, Beatrice Setnik, PhD, Michael Drass, MD, John D. Hudson, MD, Ray Clemmer, MS, Paul Meisner, PharmD, Glenn C. Pixton, MS, Veeraindar Goli, MD, Kenneth W. Sommerville, MD
Vol 10, No 5 (2014): September/October A multifactorial intervention for hospital opioid management Abstract
Mehmet Akce, MD, Anupam Suneja, MD, Cheryl Genord, RPh, Bonita Singal, MD, PhD, John A. Hopper, MD
Vol 11, No 5 (2015): September/October A pharmacokinetic evaluation of single and multiple doses of extended-release hydrocodone bitartrate in subjects experiencing surgical or osteoarthritic pain Abstract
Cynthia Y. Robinson, PhD, Christopher M. Rubino, PharmD, Stephen J. Farr, PhD
Vol 12, No 1 (2016): January/February A phase I study of d-methadone in patients with chronic pain Abstract
Natalie Moryl, MD, Cristina Tamasdan, MD, Dana Tarcatu, MD, Howard T. Thaler, PhD, Denise Correa, PhD, Richard Steingart, MD, FACC, Richard Payne, MD, Eugenie Obbens, MD, PhD
Vol 10, No 1 (2014): January/February A pilot study of nasal fentanyl for patient controlled treatment of cancer pain Abstract
M. Thronæs, MD, S. Kaasa, MD, PhD, O. Dale, MD, PhD
Vol 9, No 5 (2013): September/October A pooled analysis of patient-specific factors and efficacy and tolerability of tapentadol extended release treatment for moderate to severe chronic pain Abstract
Mila Etropolski, MD, Bernd Lange, MD, MSc, Jutta Goldberg, PhD, Achim Steup, Dipl.-Stat., Christine Rauschkolb, MD, PhD
Vol 11, No 1 (2015): January/February A primer on definitive gas and liquid chromatography drug testing: What clinicians need to know Abstract
Amadeo Pesce, PhD, Kenneth L. Kirsh, PhD, Angela Huskey, PharmD, CPE, Steven D. Passik, PhD, Catherine A. Hammett-Stabler, PhD
Vol 13, No 5 (2017): September/October A public health outbreak management framework applied to surges in opioid overdoses Abstract
Kieran Moore, MD, CCFP (EM), FCFP, MPH, DTM&H, FRCPC, Maximilien Boulet, BSc, Julia Lew, BSc, Nicholas Papadomanolakis-Pakis, BSocSc, MPA
Vol 13, No 1 (2017): January/February A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders Abstract
Sarina R. Isenberg, MA, Allysha C. Maragh-Bass, MPH, PhD, Kathleen Ridgeway, MSPH, Mary Catherine Beach, MD, MPH, Amy R. Knowlton, MPH, ScD
Vol 8, No 3 (2012): May/June A review of epidural and intrathecal opioids used in the management of postoperative pain Abstract
Borja Mugabure Bujedo, MD, Silvia González Santos, MD, Amaia Uría Azpiazu, MD
Vol 10, No 3 (2014): May/June A review of rapid-onset opioids for breakthrough pain in patients with cancer Abstract
Steven M. Simon, RPh, MD, Lee S. Schwartzberg, MD, FACP
Vol 9, No 5 (2013): September/October A review of the use of ketamine in pain management Abstract
Qutaiba A. Tawfic, MBChB, FIBMS (Anesthesiology)
Vol 10, No 1 (2014): January/February A systematic review of smartphone applications for chronic pain available for download in the United States Abstract
Lorraine S. Wallace, PhD, Lara K. Dhingra, PhD
Vol 9, No 5 (2013): September/October Aberrant behaviors in a primary care-based cohort of patients with chronic pain identified as misusing prescription opioids Abstract
Martin D. Cheatle, PhD, Charles P. O’Brien, MD, PhD, Koshy Mathai, MD, Matthew Hansen, MD, Mario Grasso, MD, Peter Yi, MD
Vol 12, No 3 (2016): May/June Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users Abstract
Naama Levy-Cooperman, PhD, Kerri A. Schoedel, PhD, Joseph L. Reiz, BSc, David Thompson, PhD, Bijan Chakaraborty, MStat, Pierre Geoffroy, MD, Kenneth J. Michalko, PharmD, MBA
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioid Special Issue Abuse Deterrent Opioids: Clinical and Public Policy Implications Abstract
Richard A. DeVito, Jr
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioid Special Issue Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder Abstract
Theresa A. Cassidy, MPH, Eileen Thorley, MPH, Ryan A. Black, PhD, Angela DeVeaugh-Geiss, PhD, Stephen F. Butler, PhD, Paul Coplan, ScD
1 - 25 of 302 Items 1 2 3 4 5 6 7 8 9 10 > >>